Explores immune cell dynamics in Guillain–Barré syndrome, suggesting pathways for new therapies.
Guillain-Barré syndrome (GBS) is an autoimmune disorder characterized by acute peripheral demyelination, leading to progressive muscle weakness and sensory loss. While CD4⁺ T cells and circulating macrophages are implicated in autoimmune neuropathies, the compositional dynamics and activation mechanisms of circulating immune cells remain elusive. Here, we performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMC) from 3 GBS patients and 2 healthy controls. A total of 51358 cells in the PBMC dataset passed the quality control. In addition, immune cell activation and recruitment were validated using mouse model single-cell datasets and rat transcriptome datasets. We delineate a T-cell differentiation–chemokine secretion axis that operates as a pathogenic hub in inflammatory neuropathy. This data resource provides an indispensable foundation for developing immunomodulatory therapies in Guillain–Barré syndrome.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: